1. Home
  2. CRI vs CDNA Comparison

CRI vs CDNA Comparison

Compare CRI & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRI
  • CDNA
  • Stock Information
  • Founded
  • CRI 1865
  • CDNA 1998
  • Country
  • CRI United States
  • CDNA United States
  • Employees
  • CRI N/A
  • CDNA N/A
  • Industry
  • CRI Apparel
  • CDNA Medical Specialities
  • Sector
  • CRI Consumer Discretionary
  • CDNA Health Care
  • Exchange
  • CRI Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • CRI 1.2B
  • CDNA 1.0B
  • IPO Year
  • CRI 2003
  • CDNA 2014
  • Fundamental
  • Price
  • CRI $30.77
  • CDNA $19.04
  • Analyst Decision
  • CRI Sell
  • CDNA Buy
  • Analyst Count
  • CRI 5
  • CDNA 6
  • Target Price
  • CRI $36.80
  • CDNA $30.33
  • AVG Volume (30 Days)
  • CRI 1.4M
  • CDNA 996.2K
  • Earning Date
  • CRI 07-25-2025
  • CDNA 07-30-2025
  • Dividend Yield
  • CRI 8.68%
  • CDNA N/A
  • EPS Growth
  • CRI N/A
  • CDNA N/A
  • EPS
  • CRI 4.51
  • CDNA 1.07
  • Revenue
  • CRI $2,812,437,000.00
  • CDNA $346,421,000.00
  • Revenue This Year
  • CRI N/A
  • CDNA $13.31
  • Revenue Next Year
  • CRI N/A
  • CDNA $15.46
  • P/E Ratio
  • CRI $6.76
  • CDNA $17.61
  • Revenue Growth
  • CRI N/A
  • CDNA 25.92
  • 52 Week Low
  • CRI $29.62
  • CDNA $13.48
  • 52 Week High
  • CRI $71.99
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • CRI 42.06
  • CDNA 55.64
  • Support Level
  • CRI $29.82
  • CDNA $18.51
  • Resistance Level
  • CRI $31.83
  • CDNA $19.62
  • Average True Range (ATR)
  • CRI 1.12
  • CDNA 0.84
  • MACD
  • CRI 0.00
  • CDNA 0.02
  • Stochastic Oscillator
  • CRI 29.64
  • CDNA 66.12

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: